{
 "name": "易威",
 "slug": "tw-1799",
 "aliases": [
  "易威生醫科技股份有限公司",
  "EASYWELL",
  "1799"
 ],
 "ticker": "1799",
 "industry": "生技醫療業",
 "website": "http://www.easywellbio.com",
 "summary": "易威（1799）是上櫃的生技醫療類股公司，1998 年成立，2008 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "易威生醫科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "EASYWELL",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2008-11-10",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "1998-08-10",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "林翰飛",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "李艾平",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 2487758940,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "http://www.easywellbio.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 138458,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-23核對官方115年9月申報資料（出表1151017），百分比按原檔保留兩位小數。原source為valueledger次級網址混入中文說明，改為可直接開啟的一手API。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 80.64,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-23核對官方115年9月申報資料（出表1151017），百分比按原檔保留兩位小數。原source為valueledger次級網址混入中文說明，改為可直接開啟的一手API。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 78.59,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-23核對官方115年9月申報資料（出表1151017），百分比按原檔保留兩位小數。原source為valueledger次級網址混入中文說明，改為可直接開啟的一手API。"
  },
  {
   "claim": "管線：TLX-001（學名未公開）",
   "value": "咳嗽｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "as_of依年報封面刊印日2026-03-15。TLX-004與TLX-024為共同開發；未把研發代號自行對應未公開成分／商品名，亦不以刊印日當核准日。"
  },
  {
   "claim": "管線：TLX-005（學名未公開）",
   "value": "膀胱過動症｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "as_of依年報封面刊印日2026-03-15。TLX-004與TLX-024為共同開發；未把研發代號自行對應未公開成分／商品名，亦不以刊印日當核准日。"
  },
  {
   "claim": "管線：TLX-004（學名未公開）",
   "value": "憂鬱症｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "as_of依年報封面刊印日2026-03-15。TLX-004與TLX-024為共同開發；未把研發代號自行對應未公開成分／商品名，亦不以刊印日當核准日。"
  },
  {
   "claim": "管線：TLX-007（學名未公開）",
   "value": "憂鬱症｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "as_of依年報封面刊印日2026-03-15。TLX-004與TLX-024為共同開發；未把研發代號自行對應未公開成分／商品名，亦不以刊印日當核准日。"
  },
  {
   "claim": "管線：TLX-015（學名未公開）",
   "value": "預防及治療產後出血｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "as_of依年報封面刊印日2026-03-15。TLX-004與TLX-024為共同開發；未把研發代號自行對應未公開成分／商品名，亦不以刊印日當核准日。"
  },
  {
   "claim": "管線：TLX-018（學名未公開）",
   "value": "出血｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "as_of依年報封面刊印日2026-03-15。TLX-004與TLX-024為共同開發；未把研發代號自行對應未公開成分／商品名，亦不以刊印日當核准日。"
  },
  {
   "claim": "管線：TLX-030（學名未公開）",
   "value": "發炎｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "as_of依年報封面刊印日2026-03-15。TLX-004與TLX-024為共同開發；未把研發代號自行對應未公開成分／商品名，亦不以刊印日當核准日。"
  },
  {
   "claim": "管線：TLX-047（學名未公開）",
   "value": "發炎｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "as_of依年報封面刊印日2026-03-15。TLX-004與TLX-024為共同開發；未把研發代號自行對應未公開成分／商品名，亦不以刊印日當核准日。"
  },
  {
   "claim": "管線：TLX-024（學名未公開）",
   "value": "癲癇｜已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "as_of依年報封面刊印日2026-03-15。TLX-004與TLX-024為共同開發；未把研發代號自行對應未公開成分／商品名，亦不以刊印日當核准日。"
  },
  {
   "claim": "管線：HH-001（沙庫巴曲纈沙坦鈉片）",
   "value": "沙庫巴曲纈沙坦鈉片（來源未列具體適應症）｜已取得中國藥證並已上市銷售｜中國大陸",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "未由通用藥理補寫適應症；年報稱已取得諾華專利轉授權，但未公開可核實的轉授權簽約日及各項金額。"
  },
  {
   "claim": "管線：TLX-041（去氨加壓素口服液）",
   "value": "兒童尿崩症｜已通過美國FDA核准｜美國",
   "unit": "",
   "as_of": "2026-03-01",
   "source": "https://www.easywellbio.com/zh-tw/news_view.php?id=247",
   "note": "來源發布日為2026-03-01，事實發生日2026-02-26，兩者分開；Eton持有除亞洲外市場銷售權，利潤分享比率未公開。"
  },
  {
   "claim": "管線：TLX-042（液態口服癲癇藥物）",
   "value": "癲癇｜已向美國FDA提出505(b)(2) NDA申請｜美國",
   "unit": "",
   "as_of": "2026-04-16",
   "source": "https://www.easywellbio.com/zh-tw/news_view.php?id=249",
   "note": "公告僅稱提出申請，不等同FDA受理或核准；預計完成時間明列無，不推算審查日期。"
  },
  {
   "claim": "管線：TLX-032（ART-501／前稱ARD-501）",
   "value": "成人自閉症類群障礙｜第2a期先導試驗已公布結果｜美國",
   "unit": "",
   "as_of": "2025-11-18",
   "source": "https://www.easywellbio.com/zh-tw/news_view.php?id=241",
   "note": "公告為小型先導研究，未寫成確證療效；本次以Tulex／ART-501查ClinicalTrials.gov未取得可核實NCT，不猜編號。"
  },
  {
   "claim": "管線：TLX-050（學名未公開）",
   "value": "神經系統用藥（具體適應症未公開）｜共同開發中（期別未公開）｜未公開",
   "unit": "",
   "as_of": "2024-12-17",
   "source": "https://www.easywellbio.com/zh-tw/news_view.php?id=231",
   "note": "提及未來美國FDA NDA，不由此推定試驗地點或商業權利地區。"
  },
  {
   "claim": "授權合作：TLX-050",
   "value": "漢達生技／Handa Neuroscience, LLC／第三方公司（未公開名稱）｜合約約定領域（未公開）｜2024-12-17",
   "unit": "",
   "as_of": "2024-12-17",
   "source": "https://www.easywellbio.com/zh-tw/news_view.php?id=231",
   "note": "此為共同開發及製造／經銷合作，非宣稱全球獨家授權。原雙方合約簽訂日2024-07-09；本筆為新增第三方的另行合約，契約日期明列2024-12-17。里程碑、費用及利潤比率保密，未填任何金額或權利金。"
  },
  {
   "claim": "管線：TLX-054（注射針劑用藥）",
   "value": "未公開｜與台耀化學共同開發（期別未公開）｜未公開",
   "unit": "",
   "as_of": "2025-11-10",
   "source": "https://www.easywellbio.com/zh-tw/news_view.php?id=239",
   "note": "僅確認公開代號及共同開發；未公開適應症、地區與精確簽約日，因此不從發稿日建立授權日期或催化劑。"
  },
  {
   "claim": "管線：TLX-034（學名未公開）",
   "value": "內分泌系統用藥｜年報業務章節列已取得美國FDA藥證｜美國",
   "unit": "",
   "as_of": "2026-03-15",
   "source": "https://www.easywellbio.com/zh-tw/data/uploads/2026/04/02/115%E5%B9%B4%E8%82%A1%E6%9D%B1%E6%9C%83%E5%B9%B4%E5%A0%B1.pdf",
   "note": "年報第82頁具名列示TLX-024及TLX-034兩項共同開發新藥；第87頁及致股東報告僅提一項，產品數目文字不一致，本筆保留來源歸屬限定，不補學名、藥證號、精確核准日，亦不由總數推論其他產品。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-23",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-1799.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}